No wearing-off effect of erenumab or fremanezumab for chronic migraine prevention: a single-center, real-world, observational study.
The present study investigates the wearing-off effect in adults with chronic migraine treated with erenumab or fremanezumab.This real-world observational study was based on pre-collected headache diaries from chronic migraine...
Read More